康泰生物最新公告：持股5%以上股东袁莉萍拟在一致行动人之间内部转让不超过2.00%股份

证券之星02-06

康泰生物(300601.SZ)公告称，公司持股5%以上股东袁莉萍拟将其持有的博普私募基金产品的部分公司股份不超过22,330,000股（不超过公司总股本比例2.00%），通过大宗交易方式转让给其一致行动人华宝万盈私募基金产品。此次股份转让计划是股东及其一致行动人之间的内部转让，不涉及向市场减持。

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2609595896?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-02-06 20:51","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2609595896","market":"hk","top_or_hot":-1,"title":"康泰生物最新公告：持股5%以上股东袁莉萍拟在一致行动人之间内部转让不超过2.00%股份","media":"证券之星","content":"<html><body><p><a href=\"https://laohu8.com/S/300601\">康泰生物</a>(300601.SZ)公告称，公司持股5%以上股东袁莉萍拟将其持有的博普私募基金产品的部分公司股份不超过22,330,000股（不超过公司总股本比例2.00%），通过大宗交易方式转让给其一致行动人<a href=\"https://laohu8.com/S/300741\">华宝</a>万盈私募基金产品。此次股份转让计划是股东及其一致行动人之间的内部转让，不涉及向市场减持。</p><p>以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。</p></body></html>","source":"stockstar","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康泰生物最新公告：持股5%以上股东袁莉萍拟在一致行动人之间内部转让不超过2.00%股份</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康泰生物最新公告：持股5%以上股东袁莉萍拟在一致行动人之间内部转让不超过2.00%股份\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-06 20:51 北京时间&nbsp;&nbsp;&nbsp;<a href=https://stock.stockstar.com/RB2026020600038548.shtml><strong>证券之星</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>康泰生物(300601.SZ)公告称，公司持股5%以上股东袁莉萍拟将其持有的博普私募基金产品的部分公司股份不超过22,330,000股（不超过公司总股本比例2.00%），通过大宗交易方式转让给其一致行动人华宝万盈私募基金产品。此次股份转让计划是股东及其一致行动人之间的内部转让，不涉及向市场减持。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号）...</p>\n\n<a href=\"https://stock.stockstar.com/RB2026020600038548.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"300601","symbol_name":"康泰生物","start_time":0,"source_url":"https://stock.stockstar.com/RB2026020600038548.shtml","article_id":"2609595896","we_media_id":"1082532455","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2609595896","pubTimestamp":1770382277,"columns":[],"sourceInfo":{"source_id":"stockstar","name":"证券之星"},"weMediaInfo":{"media_name":"证券之星","introduction":"证券之星始创于1996年，是国内领先的金融信息及综合服务平台。关注证券之星，即时获取有价值的财经资讯。","home_visible":1,"id":"1082532455","head_image":"https://community-static.tradeup.com/news/2e305640fc27210243042d09d3a7fa3f"},"summary":"康泰生物(300601.SZ)公告称，公司持股5%以上股东袁莉萍拟将其持有的博普私募基金产品的部分公司股份不超过22,330,000股（不超过公司总股本比例2.00%），通过大宗交易方式转让给其一致行动人华宝万盈私募基金产品。此次股份转让计划是股东及其一致行动人之间的内部转让，不涉及向市场减持。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"300601":"康泰生物","BK0201":"可转债","BK0239":"医药制造","BK0046":"生物疫苗"},"translate_title":"Kangtai Biotech's latest announcement: Yuan Liping, a shareholder holding more than 5% of the shares, plans to internally transfer no more than 2.00% of the shares among persons acting in concert","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300601":1.5},"content_text":"康泰生物(300601.SZ)公告称，公司持股5%以上股东袁莉萍拟将其持有的博普私募基金产品的部分公司股份不超过22,330,000股（不超过公司总股本比例2.00%），通过大宗交易方式转让给其一致行动人华宝万盈私募基金产品。此次股份转让计划是股东及其一致行动人之间的内部转让，不涉及向市场减持。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2609595896","isCrawlerRequest":true}